| Abstract | OBJECTIVE: To investigate in a double-blind placebo-controlled, parallel group study, the effects of a nutrient supplement, containing, among other ingredients, the omega-3 fatty acids eicosapentaenoic acid (1.4 g EPA), docosahexaenoic acid (0.211 g DHA), omega-6 fatty acid gamma-linolenic acid (0.5 g GLA) and micronutrients in patients with active rheumatoid arthritis (RA). DESIGN, SUBJECTS AND INTERVENTION: RA patients were randomized to receive either daily liquid nutrient supplementation or placebo for 4 months. The primary end point was the change in tender joint count at 2 and 4 months. Other clinical variables included swollen joint count, visual analogue scales for pain and disease activity, grip strength, functionality score and morning stiffness. Biochemical parameters included plasma concentrations of PUFA and vitamins C and E. SETTING: Outpatient university clinic. RESULTS: In all, 66 patients enrolled, 55 completed the study. No significant change from baseline in tender joint count or any of the other clinical parameters was detected in either group. Patients receiving nutrient supplementation, but not those receiving placebo, had significant increases in plasma concentrations of vitamin E (P=0.015), and EPA, DHA and docosapentaenoic acid concomitant with decreases of arachidonic acid (P=0.01). Intergroup differences for PUFA and vitamin E were significantly different (P=0.01 and 0.03, respectively). CONCLUSIONS: This double-blind, placebo-controlled study in RA patients did not show superior clinical benefit of daily nutrient supplementation with EPA, GLA and micronutrients at the doses tested as compared to placebo. The study adds information regarding doses of omega-3 fatty acids, below which anti-inflammatory effects in RA are not seen. |
| Authors | P H J Remans, J K Sont, L W Wagenaar, W Wouters-Wesseling, W M Zuijderduin, A Jongma, F C Breedveld, J M Van Laar
(Affiliation: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.)
|
| Journal | European journal of clinical nutrition
(Eur J Clin Nutr)
Vol. 58
Issue 6
Pg. 839-45
(Jun 2004)
ISSN: 0954-3007 [Print] England |
| PMID | 15164103
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antioxidants
- Fatty Acids, Omega-3
- Fatty Acids, Omega-6
- Fatty Acids, Unsaturated
- Micronutrients
- Vitamin E
- Eicosapentaenoic Acid
- Docosahexaenoic Acids
- Ascorbic Acid
- gamma-Linolenic Acid
|
| Topics |
- Antioxidants
(analysis)
- Arthritis, Rheumatoid
(blood, drug therapy)
- Ascorbic Acid
(blood)
- Dietary Supplements
- Docosahexaenoic Acids
(administration & dosage, blood)
- Double-Blind Method
- Eicosapentaenoic Acid
(administration & dosage, blood)
- Fatty Acids, Omega-3
(administration & dosage, blood)
- Fatty Acids, Omega-6
(administration & dosage, blood)
- Fatty Acids, Unsaturated
(administration & dosage, blood)
- Female
- Hand Strength
- Humans
- Male
- Micronutrients
(administration & dosage)
- Middle Aged
- Pain
(drug therapy, epidemiology)
- Treatment Outcome
- Vitamin E
(blood)
- gamma-Linolenic Acid
(administration & dosage, blood)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research network!
Research Interface PRO additionally includes
drill-down to evidence,
articles by author,
export to Excel,
FDA Link and
mobile subscription:
1 year subscription, $45.00 USD
    
|